BioCentury | Jun 22, 2015
Clinical News

VR942: Phase I started

...Vectura began a Phase I trial of inhaled VR942 in healthy volunteers and patients with asthma...
...Oct. 7, 2013). UCB Group (Euronext:UCB), Brussels, Belgium Vectura Group plc (LSE:VEC), Chippenham, U.K. Product: VR942...
Items per page:
1 - 1 of 1